Literature DB >> 33506324

System Xc-: a key regulatory target of ferroptosis in cancer.

Man-Ru Liu1, Wen-Tao Zhu1, Dong-Sheng Pei2.   

Abstract

Ferroptosis is a type of oxidative stress-dependent regulated necrosis characterized by excessive lipid peroxide accumulation. This novel cell death modality has been implicated in preventing cancer progression. Cancer cells tend to modulate their redox state to prevent excessive peroxidation, eventually facilitating tumor growth. System Xc- (a cystine/glutamate antiporter system) is a promising target in cancer cells for ferroptosis induction. The overexpression of system Xc-, especially its core subunit xCT, has been reported in several tumors, and these high expression levels were closely related to cancer cell proliferation, invasion, metastasis and the tumor microenvironment. xCT might serve as a novel biomarker, and its upregulation almost always indicates drug tolerance and poor survival. Therefore, system Xc- inhibition may enhance chemotherapy sensitivity and optimize patient prognosis. Here, we elaborate on the mediation of ferroptosis by suppressing system Xc- and the relevant underlying molecular mechanism in cancer cells. The spotlight on this approach to cancer treatment is creating a new horizon and pointing to future opportunities.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Ferroptosis; System Xc−; cancer treatment; xCT

Mesh:

Substances:

Year:  2021        PMID: 33506324     DOI: 10.1007/s10637-021-01070-0

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  80 in total

1.  SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.

Authors:  Monika D Polewski; Rosyli F Reveron-Thornton; Gregory A Cherryholmes; Georgi K Marinov; Karen S Aboody
Journal:  Stem Cells Dev       Date:  2017-07-27       Impact factor: 3.272

Review 2.  How do we fit ferroptosis in the family of regulated cell death?

Authors:  Howard O Fearnhead; Peter Vandenabeele; Tom Vanden Berghe
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

3.  SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.

Authors:  Zhihong Ma; Hong Zhang; Meng Lian; Changli Yue; Gehong Dong; Yulan Jin; Rui Li; Hongfei Wan; Ru Wang; Ying Wang; Jie Zhai; Hongzhi Ma; Ling Feng; Jianfeng Han; Shuzhou Liu; Youxin Guo; Jianhua Li; Yu Liu; Jugao Fang; Honggang Liu
Journal:  Oncol Rep       Date:  2017-09-20       Impact factor: 3.906

Review 4.  Ferroptosis: bug or feature?

Authors:  Scott J Dixon
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

5.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

Review 6.  Recent Progress in Ferroptosis Inducers for Cancer Therapy.

Authors:  Chen Liang; Xinglin Zhang; Mengsu Yang; Xiaochen Dong
Journal:  Adv Mater       Date:  2019-10-08       Impact factor: 30.849

7.  SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.

Authors:  Stephanie M Robert; Susan C Buckingham; Susan L Campbell; Stefanie Robel; Kenneth T Holt; Toyin Ogunrinu-Babarinde; Paula P Warren; David M White; Meredith A Reid; Jenny M Eschbacher; Michael E Berens; Adrienne C Lahti; Louis B Nabors; Harald Sontheimer
Journal:  Sci Transl Med       Date:  2015-05-27       Impact factor: 17.956

8.  Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas.

Authors:  Satoru Takeuchi; Kojiro Wada; Terushige Toyooka; Nariyoshi Shinomiya; Hideyuki Shimazaki; Kuniaki Nakanishi; Kimihiro Nagatani; Naoki Otani; Hideo Osada; Yoichi Uozumi; Hirotaka Matsuo; Hiroshi Nawashiro
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

9.  Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Authors:  Wook Joon Chung; Susan A Lyons; Gina M Nelson; Hashir Hamza; Candece L Gladson; G Yancey Gillespie; Harald Sontheimer
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

Review 10.  The SLC3 and SLC7 families of amino acid transporters.

Authors:  Dimitrios Fotiadis; Yoshikatsu Kanai; Manuel Palacín
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more
  12 in total

Review 1.  Ferroptosis Involvement in Glioblastoma Treatment.

Authors:  Andrei-Otto Mitre; Alexandru Ioan Florian; Andrei Buruiana; Armand Boer; Ioana Moldovan; Olga Soritau; Stefan Ioan Florian; Sergiu Susman
Journal:  Medicina (Kaunas)       Date:  2022-02-20       Impact factor: 2.430

2.  T lymphocyte-derived extracellular vesicles aggravate abdominal aortic aneurysm by promoting macrophage lipid peroxidation and migration via pyruvate kinase muscle isozyme 2.

Authors:  Guohui Dang; Tianrun Li; Dongmin Yang; Guangxin Yang; Xing Du; Juan Yang; Yutong Miao; Lulu Han; Xiaolong Ma; Yuwei Song; Bo Liu; Xuan Li; Xian Wang; Juan Feng
Journal:  Redox Biol       Date:  2022-02-04       Impact factor: 11.799

Review 3.  Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy.

Authors:  Xiaochen Qi; Quanlin Li; Xiangyu Che; Qifei Wang; Guangzhen Wu
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 4.  Ferroptosis: A New Road towards Cancer Management.

Authors:  Iqra Bano; Pavel Horky; Syed Qamar Abbas; Muhammad Majid; Akram Hafiz Muhammad Bilal; Fawad Ali; Tapan Behl; Syed Shams Ul Hassan; Simona Bungau
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

Review 5.  Non-coding RNAs and ferroptosis: potential implications for cancer therapy.

Authors:  Amar Balihodzic; Felix Prinz; Michael A Dengler; George A Calin; Philipp J Jost; Martin Pichler
Journal:  Cell Death Differ       Date:  2022-04-14       Impact factor: 12.067

Review 6.  Ferroptosis and Its Emerging Role in Pre-Eclampsia.

Authors:  Zhixian Chen; Jianfeng Gan; Mo Zhang; Yan Du; Hongbo Zhao
Journal:  Antioxidants (Basel)       Date:  2022-06-28

Review 7.  Mechanisms of ferroptosis in chronic kidney disease.

Authors:  Wen-Qing Zhuo; Yi Wen; Hui-Jun Luo; Zhu-Lin Luo; Li Wang
Journal:  Front Mol Biosci       Date:  2022-08-24

8.  MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway.

Authors:  Ye Zhang; Yanze Li; Qiangmin Qiu; Zhiyuan Chen; Yang Du; Xiuheng Liu
Journal:  Oxid Med Cell Longev       Date:  2022-08-22       Impact factor: 7.310

Review 9.  The molecular mechanisms of ferroptosis and its role in glioma progression and treatment.

Authors:  Mengyang Lu; Yuanshuai Zhou; Linjuan Sun; Shaheryar Shafi; Nafees Ahmad; Minxuan Sun; Jun Dong
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

Review 10.  MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells.

Authors:  Colleen Yi; Ai-Ming Yu
Journal:  Front Mol Biosci       Date:  2022-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.